Literature DB >> 15237693

High remnant lipoprotein levels in patients with variant angina.

Kunihisa Miwa1, Toshinori Makita, Katsuhisa Ishii, Nobuaki Okuda, Ataru Taniguchi.   

Abstract

BACKGROUND: Dyslipidemia with increased oxidative stress but without elevation of low-density lipoprotein cholesterol has been recently implicated in the pathogenesis of coronary vasospasm. HYPOTHESIS: Disordered triglyceride-rich lipoprotein metabolism may be linked to the genesis of coronary artery spasm.
METHODS: Both serum remnant lipoprotein (RLP) and alpha-tocopherol levels were determined in 18 patients with the active stage of variant angina (VA), in 16 patients with the inactive stage of variant angina (IVA), and in 19 control subjects (CONTROL).
RESULTS: The RLP levels were significantly (p < 0.05) higher in VA (6.4 +/- 2.7 mg/dl) than in IVA (4.4 +/- 1.5 mg/dl). In contrast, alpha-tocopherol levels were significantly lower in VA than that in CONTROL. Serum trigyceride levels were not significantly different among the study groups, although serum high-density lipoprotein cholesterol levels were significantly lower in VA than in CONTROL. Smoking was significantly (p < 0.05) more prevalent in VA (72%) than in IVA (25%) and CONTROL (37%). Serum RLP levels correlated positively with triglyceride levels (R = 0.73) and correlated inversely with alpha-tocopherol levels (R = -0.31) significantly in all study subjects.
CONCLUSIONS: Patients with active stage of variant angina had higher RLP levels than inactive patients with variant angina and lower alpha-tocopherol levels than control subjects. Disordered triglyceride-rich lipoprotein metabolism with increased oxidative stress appears to be linked to the activity of coronary vasospasm, suggesting a possible role in its pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15237693      PMCID: PMC6653988          DOI: 10.1002/clc.4960270608

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  30 in total

Review 1.  Triglyceride-rich lipoprotein remnant particles and risk of atherosclerosis.

Authors:  H N Hodis
Journal:  Circulation       Date:  1999-06-08       Impact factor: 29.690

2.  Remnant lipoproteins induce proatherothrombogenic molecules in endothelial cells through a redox-sensitive mechanism.

Authors:  H Doi; K Kugiyama; H Oka; S Sugiyama; N Ogata; S I Koide; S I Nakamura; H Yasue
Journal:  Circulation       Date:  2000-08-08       Impact factor: 29.690

3.  Formation of high density lipoprotein2-like particles during lipolysis of very low density lipoproteins in vitro.

Authors:  J R Patsch; A M Gotto; T Olivercrona; S Eisenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1978-09       Impact factor: 11.205

4.  Comparative sensitivity of intracoronary injection of acetylcholine for the induction of coronary spasm in patients with various types of angina pectoris.

Authors:  K Miwa; M Fujita; M Ejiri; S Sasayama
Journal:  Am Heart J       Date:  1990-09       Impact factor: 4.749

5.  Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.

Authors:  M H Frick; O Elo; K Haapa; O P Heinonen; P Heinsalmi; P Helo; J K Huttunen; P Kaitaniemi; P Koskinen; V Manninen
Journal:  N Engl J Med       Date:  1987-11-12       Impact factor: 91.245

6.  Improvement of endothelial vasomotor dysfunction by treatment with alpha-tocopherol in patients with high remnant lipoproteins levels.

Authors:  K Kugiyama; T Motoyama; H Doi; H Kawano; N Hirai; H Soejima; Y Miyao; K Takazoe; Y Moriyama; Y Mizuno; R Tsunoda; H Ogawa; T Sakamoto; S Sugiyama; H Yasue
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

7.  Remnant-like particle cholesterol, triglycerides, and insulin resistance in nonobese Japanese type 2 diabetic patients.

Authors:  A Taniguchi; M Fukushima; M Sakai; K Miwa; T Makita; I Nagata; S Nagasaka; K Doi; T Okumura; A Fukuda; H Kishimoto; T Fukuda; S Nakaishi; K Tokuyama; Y Nakai
Journal:  Diabetes Care       Date:  2000-12       Impact factor: 19.112

8.  Detection of the "midband" lipoprotein in patients with coronary artery spasm.

Authors:  K Miwa; K Nakagawa; K Suzuki; H Inoue
Journal:  Clin Cardiol       Date:  2001-03       Impact factor: 2.882

9.  Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state.

Authors:  J R Patsch; G Miesenböck; T Hopferwieser; V Mühlberger; E Knapp; J K Dunn; A M Gotto; W Patsch
Journal:  Arterioscler Thromb       Date:  1992-11

10.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

Authors:  W P Castelli; R J Garrison; P W Wilson; R D Abbott; S Kalousdian; W B Kannel
Journal:  JAMA       Date:  1986-11-28       Impact factor: 56.272

View more
  2 in total

Review 1.  Remnant lipoproteins and atherosclerosis.

Authors:  ThB Twickler; G M Dallinga-Thie; M J Chapman; J S Cohn
Journal:  Curr Atheroscler Rep       Date:  2005-03       Impact factor: 5.113

2.  Coronary vasomotor response to intracoronary acetylcholine injection, clinical features, and long-term prognosis in 873 consecutive patients with coronary spasm: analysis of a single-center study over 20 years.

Authors:  Koji Sato; Koichi Kaikita; Naoki Nakayama; Eiji Horio; Hiromi Yoshimura; Takamichi Ono; Keisuke Ohba; Kenichi Tsujita; Sunao Kojima; Shinji Tayama; Seiji Hokimoto; Kunihiko Matsui; Seigo Sugiyama; Hiroshige Yamabe; Hisao Ogawa
Journal:  J Am Heart Assoc       Date:  2013-07-15       Impact factor: 5.501

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.